Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosures on the Nutrition Facts Panel (NFP)

ICR 200703-0910-011

OMB: 0910-0532

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement B
0000-00-00
Supplementary Document
0000-00-00
Supplementary Document
0000-00-00
Supplementary Document
0000-00-00
Supplementary Document
0000-00-00
Supplementary Document
0000-00-00
Supporting Statement A
2007-06-26
ICR Details
0910-0532 200703-0910-011
Historical Active 200311-0910-007
HHS/FDA
Experimental Study of Possible Footnotes and Cueing Schemes to Help Consumers Interpret Quantitative Trans Fat Disclosures on the Nutrition Facts Panel (NFP)
Reinstatement without change of a previously approved collection   No
Regular
Approved with change 06/28/2007
Retrieve Notice of Action (NOA) 03/21/2007
If changes to the questionnaire and related materials are made after pre-testing, FDA shall submit the final versions for OMB approval via ROCIS. The study design is appropriate for the purpose of the study identified in the supporting statement. However, in describing the data collected and results of the analysis, FDA will clearly acknowledge that the data does not provide nationally representative estimates of consumer attitudes, knowledge, behaviors, etc.
  Inventory as of this Action Requested Previously Approved
06/30/2010 36 Months From Approved
3,280 0 0
820 0 0
0 0 0

An experimental study of possible footnotes and cueing schemes to help consumers interpret quantitative trans fat disclosures on the Nutrition Facts Panel of the food label.

US Code: 21 USC 393 Name of Law: FFDCA
  
None

Not associated with rulemaking

  71 FR 6079 02/06/2006
72 FR 10220 03/07/2007
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 3,280 0 0 3,279 0 1
Annual Time Burden (Hours) 820 0 0 10 0 810
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This collection of information was discontinued in 2004. FDA is now ready to conduct the study and is reinstating this information collection.

$204,500
Yes Part B of Supporting Statement
No
Uncollected
Uncollected
Uncollected
Uncollected
Saleda Perryman

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
03/21/2007


© 2024 OMB.report | Privacy Policy